Company
Radiomer Therapeutics
| Industry | Fannin Partners-founded company that is developing targeted radiopharmaceuticals / radioligand therapies for theranostic applications, has been launched with undisclosed pre-seed funding. |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Radiomer Therapeutics | pre-seed | 2024-05-30 |